Technological Innovations and Market Drivers in the US Ureteral Stents Market: Enhancing Patient Outcomes through Material Science and Design
The US Ureteral Stents Market is poised for substantial growth, with estimations showing an increase from about USD 130 million in 2024 to nearly USD 240 million by 2035, reflecting a CAGR of approximately 5.732%. A major force fueling this market is innovation in stent design and materials—manufacturers are focusing on biocompatible polymers, drug-eluting coatings, biodegradable materials, and designs that reduce encrustation and minimize irritation. Meanwhile, demand is rising due to increasing prevalence of urological disorders—kidney stones, urinary tract infections, and blockage due to strictures—and the growing elderly population in the US. Advances in minimally invasive surgery also encourage stent use, as urologists and device makers work together to reduce patient discomfort, risk of complications, and recovery times. Regulatory oversight by the FDA ensures that new stent solutions meet safety and efficacy standards,…